Evidence map›Paper›PMID 41602756›Full record

ReviewFrontiers in microbiology2025

AI-powered analysis of viral metagenomic sequencing data for rapid outbreak investigation and novel pathogen discovery.

David Chisompola, Emmanuel Luwaya, John Nzobokela, Phinnoty Mwansa, Martin Chakulya

Abstract readReview
In one paragraph

Review in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

David ChisompolaSchool of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia.
Emmanuel LuwayaSchool of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia.
John NzobokelaSchool of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia.
Phinnoty MwansaSchool of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia.
Martin ChakulyaSchool of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emerging viral outbreaks continue to pose a persistent global health threat, underscoring the urgent need for a shift from reactive to proactive health security strategies. Viral metagenomic next-generation sequencing (mNGS) offers an unbiased, powerful approach to pathogen detection and discovery, yet its utility has been constrained by the computational complexity and slow turnaround time of data analysis during outbreak crises. The integration of artificial intelligence (AI) and mNGS is dismantling these barriers, enabling faster, more scalable outbreak response. This review synthesizes how AI-driven analytics are transforming mNGS applications, from genome assembly to sequence classification, using advanced architectures such as convolutional neural networks, recurrent neural networks, and transformers. Beyond accelerating workflows, AI's capacity for pattern recognition outperforms traditional homology-based methods, facilitating the discovery of novel viral families and tracing hidden transmission chains through anomaly detection. Nonetheless, critical challenges remain, including limited training data, the interpretability of AI models, and resource-intensive computational demands that risk widening an "AI divide" in global health. We evaluate these obstacles and highlight forward-looking strategies, including federated learning for privacy-preserving data sharing and explainable AI for improving trust and biological insight. Looking ahead, we envision an "AI-first" paradigm for outbreak preparedness, anchored in integrated "Digital Immune Systems" for continuous, global-scale surveillance. By framing the synergy between mNGS and AI as a transformative leap, this review underscores its potential to strengthen resilience against future pandemics.

Indexed as

artificial intelligenceoutbreak investigationpandemic preparednesspathogen discoveryviral metagenomics

Identifiers

PMID41602756
PMCPMC12833367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.